Geode Capital Management, LLC Cin Cor Pharma, Inc. Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$10.75 - $29.84 $700,652 - $1.94 Million
65,177 Added 18.35%
420,310 $5.17 Million
Q3 2022

Nov 14, 2022
BUY
$19.9 - $38.94 $2.48 Million - $4.85 Million
124,591 Added 54.04%
355,133 $11.7 Million
Q2 2022

Aug 12, 2022
BUY
$13.67 - $25.74 $295,873 - $557,116
21,644 Added 10.36%
230,542 $4.34 Million
Q1 2022

May 13, 2022
BUY
$14.13 - $28.49 $2.95 Million - $5.95 Million
208,898 New
208,898 $3.66 Million

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email